|
European Atherosclerosis Society Congress May 29 - June 1
|
4
|
Resverlogix Corp.
|
May 26, 2016 11:12AM
|
|
Events/Webcasts Page Updated
|
5
|
Resverlogix Corp.
|
Sep 14, 2016 02:17PM
|
|
Everyone just take a deep breath
|
6
|
Resverlogix Corp.
|
Apr 20, 2017 10:15AM
|
|
Executive Video Twitter Post/Link to RVX video from January
|
1
|
Resverlogix Corp.
|
Jul 20, 2015 10:41PM
|
|
Fabry Disease More Common Than Previously Thought, Experts Say
|
1
|
Resverlogix Corp.
|
Mar 27, 2019 11:13AM
|
|
Favor
|
4
|
Resverlogix Corp.
|
Sep 26, 2019 10:26AM
|
|
FDA grants Fast Track designation to Jardiance for the treatment of CKD
|
2
|
Resverlogix Corp.
|
Mar 12, 2020 09:22AM
|
|
Fierce Biotech BET inhibitor/PD-L1 cancer article
|
5
|
Zenith Epigenetics
|
Sep 15, 2016 10:56AM
|
|
Final Checklist for Management
|
3
|
Resverlogix Corp.
|
Jul 28, 2016 05:18PM
|
|
Final Checklist for Management
|
4
|
Resverlogix Corp.
|
Jul 28, 2016 05:19PM
|
|
Final Short Term Prospectus and other Related Documents now on SEDAR
|
5
|
Resverlogix Corp.
|
Jun 04, 2019 01:02PM
|
|
Financial Statements and MD&A for the Period Ending November 30, 2018
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 30, 2019 01:35PM
|
|
Financials and MD&A on SEDAR
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jan 30, 2017 10:16PM
|
|
First full publication of BET inhibition in solid cancers
|
7
|
Zenith Epigenetics
|
May 11, 2018 11:43AM
|
|
First presentation of BETonMACE data at ESC 2019?
|
5
|
Resverlogix Corp.
|
Apr 30, 2019 01:24PM
|
|
Flu vs. Covid19
|
7
|
Resverlogix Corp.
|
Mar 31, 2020 12:30PM
|
|
For Toniv, Re:Zenith
|
5
|
Resverlogix Corp.
|
Oct 29, 2015 10:00PM
|
|
Former Zacks biotech analyst Napodano charged with fraud
|
2
|
Resverlogix Corp.
|
Sep 27, 2017 01:06PM
|
|
Framework for Addressing Residual CVD Risk
|
5
|
Resverlogix Corp.
|
Apr 13, 2018 01:03PM
|
|
From CANTOS to CIRT to COLCOT to Clinic
|
2
|
Resverlogix Corp.
|
Mar 12, 2020 09:25AM
|
